TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34180702

Group type: EXPERIMENTAL
Intervention: Prodromal symptoms (binge eating, compensatory behaviors, weight/shape overvaluation, fear of weight gain, feeling fat)
Number of subjects: 1952

Group type: EXPERIMENTAL
Intervention: Weight/shape overvaluation, fear of weight gain, lower than expected body mass index
Number of subjects: 1952

Group type: EXPERIMENTAL
Intervention: Prodromal symptoms and established risk factors
Number of subjects: 1952
Study: 33827653

Group type: EXPERIMENTAL
Intervention: VR immersion group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Routine night-shift group
Number of subjects: 30
Study: 32246953

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fingerprick glucose monitoring
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (CGM and fingerprick)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Frequency of glucose testing and booklet entry
Number of subjects: 40
Study: 35762503

Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 101

Group type: COMPARATOR
Intervention: Darunavir/cobicistat
Number of subjects: 101
Study: 36087586

Group type: EXPERIMENTAL
Intervention: 5 μg R21/25 μg Matrix‐M
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: 5 μg R21/50 μg Matrix‐M
Number of subjects: 409

Group type: COMPARATOR
Intervention: Control vaccine (Rabivax‐S rabies vaccine)
Number of subjects: 409
Study: 32449213

Group type: EXPERIMENTAL
Intervention: Lasmiditan (50 mg, 100 mg, 200 mg)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Lasmiditan (100 mg, 200 mg)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Alprazolam (1 mg)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Diphenhydramine (50 mg)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 35998947

Group type: EXPERIMENTAL
Intervention: Meperidine-Ketorolac combination (1 mg/kg IV meperidine and 30 mg IV ketorolac)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Meperidine alone (1 mg/kg IV meperidine)
Number of subjects: 88
Study: 36264909

Group type: EXPERIMENTAL
Intervention: Steady Feet (SF) exercise programme
Number of subjects: 260

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 260
Study: 33495093

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) distraction
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 20
Study: 34575292

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% with 1:200,000 epinephrine plus 2 mL of clonidine 1 µg/kg and normal saline 0.9% (Group 2)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lidocaine 2% with 1:200,000 epinephrine plus 2 mL of normal saline 0.9% (Group 1)
Number of subjects: 24
Study: 33295294

Group type: EXPERIMENTAL
Intervention: Natural language processing (NLP) for extracting clinical text entities from pathology reports
Number of subjects: 1848

Group type: EXPERIMENTAL
Intervention: Mapping extracted clinical and genetic information to OMOP CDM
Number of subjects: 1848
Study: 35321823

Group type: EXPERIMENTAL
Intervention: Ticagrelor in addition to aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0
Study: 33333767

Group type: EXPERIMENTAL
Intervention: Bioactive compounds enriched infant formula (EF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard infant formula (SF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Breastfed (BF)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Maternal IQ
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Maternal educational level
Number of subjects: 70
Study: 36206510

Group type: EXPERIMENTAL
Intervention: Double-bundle U-Dos technique (DB group)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Single-bundle technique (SB group)
Number of subjects: 72
Study: 34358486

Group type: EXPERIMENTAL
Intervention: Probiotics (Bacillus coagulans MY01 and Bacillus subtilis MY02, 2·5 × 10^9 colony-forming units per capsule, consumed twice per day for 8 weeks)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (consumed twice per day for 8 weeks)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 32191532

Group type: EXPERIMENTAL
Intervention: EE 30 µg/DRSP 3 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: EE 30 µg/CMA 2 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: EE 30 µg/DNG 2 mg
Number of subjects: 60
Study: 35513384

Group type: EXPERIMENTAL
Intervention: Pharmacist-led therapeutic carbohydrate and energy restriction
Number of subjects: 0
Study: 33308285

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34971039

Group type: EXPERIMENTAL
Intervention: In-person family contact
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Text/email time with friends during COVID-19
Number of subjects: 146
Study: 35953423

Group type: EXPERIMENTAL
Intervention: Standardized patient (n=40)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Low-fidelity mannequin simulator (n=41)
Number of subjects: 81
Study: 33541232

Group type: EXPERIMENTAL
Intervention: Touch-and-go bench press
Number of subjects: 113

Group type: COMPARATOR
Intervention: Concentric-only bench press
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Repetitions-to-failure test
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Correlation with error in 1RM estimation
Number of subjects: 113
Study: 32213105

Group type: EXPERIMENTAL
Intervention: Anetumab ravtansine at 6.5 mg/kg once every 3 weeks
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Anetumab ravtansine at 1.8 mg/kg once per week
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Anetumab ravtansine at 2.2 mg/kg once per week
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Anetumab ravtansine (various doses)
Number of subjects: 148
Study: 35280163

Group type: EXPERIMENTAL
Intervention: Culturally adapted digital sleep intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 66
Study: 33266325

Group type: EXPERIMENTAL
Intervention: High Protein (HP) drinks
Number of subjects: 391

Group type: COMPARATOR
Intervention: Normal Protein (NP) drinks
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Adults
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Elderly
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Weight categories, genders, and sites
Number of subjects: 391
Study: 32787676

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 881

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 881
Study: 32603560

Group type: EXPERIMENTAL
Intervention: Augmentation with aripiprazole
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Switching to bupropion
Number of subjects: 1522

Group type: EXPERIMENTAL
Intervention: Augmentation with bupropion
Number of subjects: 1522
Study: 33147492

Group type: EXPERIMENTAL
Intervention: Laparoscopic adhesiolysis
Number of subjects: 184

Group type: COMPARATOR
Intervention: Controlled ovarian stimulation and IUI
Number of subjects: 184
Study: 35614437

Group type: EXPERIMENTAL
Intervention: Onset of physical disability
Number of subjects: 8568

Group type: COMPARATOR
Intervention: No onset of physical disability or dementia
Number of subjects: 8568
Study: 34913294

Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg twice daily)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Ganirelix acetate (0.25 mg subcutaneously daily)
Number of subjects: 122
Study: 32588878

Group type: EXPERIMENTAL
Intervention: Caplacizumab
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 36088351

Group type: EXPERIMENTAL
Intervention: Enhanced Replicating Effective Programs (REP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard implementation
Number of subjects: 0
Study: 33491323

Group type: EXPERIMENTAL
Intervention: 1.5 oz of almonds daily for 12 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: 1.8 oz of pretzels daily for 12 weeks
Number of subjects: 39
Study: 32605655

Group type: EXPERIMENTAL
Intervention: Drug treatment group
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Surgical treatment group
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment group
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Surgery and postoperative orthodontic group
Number of subjects: 352

Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 352
Study: 33065165

Group type: COMPARATOR
Intervention: TAVI with PSs
Number of subjects: 9498

Group type: COMPARATOR
Intervention: TAVI with hdPSs
Number of subjects: 9498
Study: 32187767

Group type: EXPERIMENTAL
Intervention: Take-home HIV test kit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard HIV testing methods
Number of subjects: 0
Study: 35037386

Group type: COMPARATOR
Intervention: 1 ml minoxidil for external use twice a day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3500 IU basic fibroblast growth factor (bFGF) and 1 ml minoxidil for external use twice a day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 33161036

Group type: EXPERIMENTAL
Intervention: Microneedle (MN) patch
Number of subjects: 30

Group type: COMPARATOR
Intervention: 30G hypodermic needle (positive control)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Microneedle patch with needles laying flat (negative control)
Number of subjects: 30
Study: 32916656

Group type: EXPERIMENTAL
Intervention: Dark Chocolate (DC)
Number of subjects: 12
Study: 33385633

Group type: EXPERIMENTAL
Intervention: Antipsychotic medication
Number of subjects: 59
Study: 32448277

Group type: EXPERIMENTAL
Intervention: TIDieR checklist
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CERT checklist
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CONTENT scale
Number of subjects: 10
Study: 35676335

Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patch (14 mg daily)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 34182060

Group type: COMPARATOR
Intervention: Low abrasivity NaF and water control
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Medium abrasivity NaF and SnF2
Number of subjects: 96
Study: 36245011

Group type: EXPERIMENTAL
Intervention: Intralesional Candida antigen every 3 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Weekly DPCP application
Number of subjects: 50
Study: 33407828

Group type: EXPERIMENTAL
Intervention: Hochu‐ekki‐to (HET) - 9 tablets, 2 times per day for 8 weeks
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Placebo - 9 tablets, 2 times per day for 8 weeks
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: HET
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6000
Study: 33155034

Group type: EXPERIMENTAL
Intervention: SaLeish vaccine (fusion protein of SP15 and LeIF)
Number of subjects: 0
Study: 36179438

Group type: EXPERIMENTAL
Intervention: Online cognitive behavioral therapy (CBT) program
Number of subjects: 563

Group type: COMPARATOR
Intervention: Access to anxiety resources on a static website (active comparator)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 563
Study: 33788420

Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 162

Group type: COMPARATOR
Intervention: Non-statin users
Number of subjects: 162
Study: 32124549

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No adjuvant radiotherapy (RT)
Number of subjects: 36
Study: 33823560

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose low molecular weight heparin (LMWH) - enoxaparin 1 mg/kg SQ/BID (CrCl ≥ 30 ml/min) or 0.5 mg/kg (CrCl 15-30 ml/min)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Prophylactic/intermediate-dose LMWH or unfractionated heparin (UFH)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose LMWH
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Major bleeding
Number of subjects: 308
Study: 33292892

Group type: EXPERIMENTAL
Intervention: Parents as Teachers (PAT) intervention
Number of subjects: 132

Group type: COMPARATOR
Intervention: Parents as Teachers (PAT) control
Number of subjects: 132
Study: 34819126

Group type: EXPERIMENTAL
Intervention: Tocovid capsules
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo containing palm superolein
Number of subjects: 202
Study: 35361621

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) in elderly patients with T2D
Number of subjects: 2535

Group type: EXPERIMENTAL
Intervention: Elderly patients with T2D with AF
Number of subjects: 2535
Study: 34103326

Group type: EXPERIMENTAL
Intervention: Community and District-management Empowerment for Scale-up (CODES)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (comparison areas)
Number of subjects: 16
Study: 32407583

Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) intervention for 12 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 36272277

Group type: EXPERIMENTAL
Intervention: Extended infusion of ampicillin/sulbactam (infused over 4 hours)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Intermittent infusion of ampicillin/sulbactam (infused over 30 minutes)
Number of subjects: 136
Study: 32965057

Group type: EXPERIMENTAL
Intervention: Cannabidiol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35396602

Group type: EXPERIMENTAL
Intervention: Domagrozumab (myostatin inhibitor)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Domagrozumab
Number of subjects: 120
Study: 34292820

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB) 266 mg (20 mL)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard bupivacaine (SB)
Number of subjects: 63
Study: 32729896

Group type: EXPERIMENTAL
Intervention: Target interlesion distance (ILD) of 5.0-6.0 mm
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Target interlesion distance (ILD) of 3.0-4.0 mm
Number of subjects: 42
Study: 35793277

Group type: EXPERIMENTAL
Intervention: Gardening
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Art-making
Number of subjects: 32
Study: 32956528

Group type: EXPERIMENTAL
Intervention: 3D printed teeth models
Number of subjects: 90
Study: 32217791

Group type: EXPERIMENTAL
Intervention: Oral iron (PILL)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Transdermal iron (PATCH)
Number of subjects: 29
Study: 34903440

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises for 15 minutes preoperatively and on postoperative days 1, 2, and 3 after breathing exercise training.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Routine treatments and care process (Control group).
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises.
Number of subjects: 63
Study: 32618725

Group type: EXPERIMENTAL
Intervention: Fecal microbial transplantation (FMT)
Number of subjects: 0
Study: 35959574

Group type: EXPERIMENTAL
Intervention: Early-intervention group (1-week after symptom onset)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Late-intervention group (2-week after symptom onset)
Number of subjects: 31

Group type: COMPARATOR
Intervention: General treatment group
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Early-intervention group
Number of subjects: 31
Study: 33555337

Group type: EXPERIMENTAL
Intervention: Prenatal repair
Number of subjects: 154

Group type: COMPARATOR
Intervention: Postnatal repair
Number of subjects: 154
Study: 34847737

Group type: EXPERIMENTAL
Intervention: Palliative care consultation during hospital admission
Number of subjects: 365

Group type: COMPARATOR
Intervention: Other inpatient wards (control)
Number of subjects: 365
Study: 33098161

Group type: EXPERIMENTAL
Intervention: TFC-1067
Number of subjects: 48

Group type: COMPARATOR
Intervention: 2% hydroquinone cream
Number of subjects: 48
Study: 34969272

Group type: EXPERIMENTAL
Intervention: Line-to-line cementing
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard cementing
Number of subjects: 48
Study: 36124597

Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) model
Number of subjects: 9422

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) model
Number of subjects: 9422
Study: 34668872

Group type: EXPERIMENTAL
Intervention: e‐CCM app on smartphones
Number of subjects: 6965

Group type: COMPARATOR
Intervention: paper‐based CCM (control)
Number of subjects: 6965
Study: 32316468

Group type: EXPERIMENTAL
Intervention: Methodology for detecting changes in travel behavior patterns using GPS/GNSS data and a clustering algorithm.
Number of subjects: 3
Study: 35088103

Group type: EXPERIMENTAL
Intervention: 40 ng/kg/day calcitriol
Number of subjects: 68

Group type: COMPARATOR
Intervention: 20 ng/kg/day calcitriol
Number of subjects: 68
Study: 32843299

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (rTMS) for 2 sessions of 10 Hz rTMS (40 trains of 50 pulses with a 20-second intertrain interval) to the left dorsolateral prefrontal cortex
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 66
Study: 32385167

Group type: EXPERIMENTAL
Intervention: 12.7 g of MSG
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 32289310

Group type: EXPERIMENTAL
Intervention: Dynamic monitoring of bleeding risk using the HAS-BLED score via mAFA
Number of subjects: 1793

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1793
Study: 35950537

Group type: EXPERIMENTAL
Intervention: AHCC®
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 33619204

Group type: EXPERIMENTAL
Intervention: Minimally invasive distal pancreatectomy (MIDP)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Open distal pancreatectomy
Number of subjects: 294
Study: 32092081

Group type: EXPERIMENTAL
Intervention: Electrical stimulation protocol (2-6mA)
Number of subjects: 34
Study: 35811053

Group type: EXPERIMENTAL
Intervention: aPDT with TBO and diode laser (635 nm)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: aPDT with ICG and diode laser (808 nm)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional disinfection method with Phosphoric acid 37%
Number of subjects: 71
Study: 33789445

Group type: EXPERIMENTAL
Intervention: β‐alanine (n=11)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PL, n=5)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inactive VL
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Type-I fibers in inactive VL
Number of subjects: 16
Study: 32253597

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Non-TXA
Number of subjects: 51
Study: 34292116

Group type: EXPERIMENTAL
Intervention: Evidence-based U = U message
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Opinion-based message
Number of subjects: 314

Group type: COMPARATOR
Intervention: Control message
Number of subjects: 314
Study: 34393156

Group type: EXPERIMENTAL
Intervention: ZOL combined with APAP
Number of subjects: 109

Group type: COMPARATOR
Intervention: ZOL without APAP (non-APAP group)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: ZOL combined with ELD
Number of subjects: 109

Group type: COMPARATOR
Intervention: ZOL without ELD (non-ELD group)
Number of subjects: 109
Study: 34963099

Group type: EXPERIMENTAL
Intervention: Human umbilical cord-derived mesenchymal stem cells (UC-MSC)
Number of subjects: 100
Study: 32279430

Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrohysteropexy (LSH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vaginal sacrospinous hysteropexy (SSHP)
Number of subjects: 0
Study: 35820076

Group type: EXPERIMENTAL
Intervention: Candidates with tattoos
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Candidates with purple hair
Number of subjects: 183

Group type: COMPARATOR
Intervention: Candidates with a Liverpool English accent
Number of subjects: 183
Study: 34920723

Group type: EXPERIMENTAL
Intervention: Rewarming at 0.25 °C/h
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rewarming at 0.50 °C/h
Number of subjects: 50
Study: 34206175

Group type: EXPERIMENTAL
Intervention: Resistance training (body weight, elastic bands, water canes) twice per week for eight months
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (informed about national PA guidelines and received motivational talks)
Number of subjects: 101
Study: 33051340

Group type: EXPERIMENTAL
Intervention: Pembrolizumab + Stereotactic Body Radiation Therapy (SBRT; 50 Gy in 4 fractions)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pembrolizumab + Traditional Radiation Therapy (45 Gy in 15 fractions)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Pembrolizumab alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pembrolizumab + RT (regardless of schema)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pembrolizumab with low PD-L1 expression
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pembrolizumab without low PD-L1 expression
Number of subjects: 100
Study: 33372218

Group type: EXPERIMENTAL
Intervention: Cervical disc arthroplasty (CDA) using the Mobi-C® Cervical Disc
Number of subjects: 0
Study: 32100496

Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with lifestyle control
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lifestyle control
Number of subjects: 90
Study: 35397527

Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication review
Number of subjects: 211

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 211
Study: 34600562

Group type: EXPERIMENTAL
Intervention: Memory T cells plus standard of care (SoC)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Natural Killer (NK) cells plus standard of care (SoC)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 182
Study: 32838470

Group type: EXPERIMENTAL
Intervention: Non-vitamin K dependent oral anticoagulants (NOACs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left atrial appendage occlusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin K antagonists
Number of subjects: 0